Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine Supplementation and Propofol Requirements During Hysteroscopy
ChiCTR2500104602Phase 4Not yet recruiting
- Sponsor
- Affiliated Women and Children's Hospital of Ningbo University
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine (5 arms), sponsored by Affiliated Women and Children's Hospital of Ningbo University. Primary endpoint: Half-effective effect compartment concentration of propofol for inhibiting cervical dilation response. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
esketamine
Beyond the preview
Go deeper on ChiCTR2500104602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500104602.